Video-Assisted Thoracic Surgery Lobectomy for Non-SmallCell Lung Cancer: Experience of 133 Cases.
- Author:
Hyeong Ryul KIM
1
;
Jeong Su CHO
;
Hee Jin JANG
;
Sang Cheol LEE
;
Eun Suk CHOI
;
Sanghoon JHEON
;
Sook Whan SUNG
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Korea. swsung@snubh.org
- Publication Type:Original Article
- Keywords:
Video-assisted thoracoscopy;
Lobectomy;
Carcinoma, non-small cell, lung
- MeSH:
Adenocarcinoma;
Carcinoma, Non-Small-Cell Lung;
Chest Tubes;
Female;
Hemorrhage;
Humans;
Length of Stay;
Lung;
Lymph Nodes;
Positron-Emission Tomography and Computed Tomography;
Survival Rate;
Thoracic Surgery, Video-Assisted;
Thoracotomy;
Thorax
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2009;42(5):615-623
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: We evaluated the feasibility and the efficacy of Video-Assisted Thoracic Surgery (VATS) lobectomy for treating patients with non-small cell lung cancer (NSCLC) and we compared the outcomes of VATS lobectomy with those of open lobectomy. MATERIAL AND METHOD: From 2003 to March 2008, 133 NSCLC patients underwent VATS lobectomy. The patients were selected on the basis of having clinical stage I disease on the chest CT and PET scan. The outcomes of 202 patients who underwent open lobectomy (OL group) for clinical stage I NSCLC were evaluated to compare their results with those of the patients who underwent VATS lobectomy (the VL group). RESULT: The number of females and the number of patients with adenocarcinoma and stage IA disease were greater in VL group (p<0.05). There was no operative mortality or major complications in the VL group. Conversion to thoracotomy was needed in 8 cases (6%), which was mostly due to bleeding. The chest tube indwelling time and the length of the postoperative hospital stay were significantly shorter in the VL group (p<0.001). The number of dissected lymph nodes and the size of tumor were significantly smaller in the VL group (p<0.001). For the pathologic stage I patients, there was no significant difference in the three-year survival rates between the two groups (p=0.15). CONCLUSION: VATS lobectomy is a safe procedure with low operative mortality and morbidity. VATS lobectomy is feasible for early stage NSCLC and it provides outcomes that are comparable to those for open lobectomy. Further long-term data are needed
